| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 90.718 | 50.243 | 1.162 | - | - | - | - | - |
| Total Income - EUR | - | - | 92.688 | 53.924 | 1.210 | - | - | - | - | - |
| Total Expenses - EUR | - | - | 39.662 | 52.970 | 9.877 | - | - | - | - | - |
| Gross Profit/Loss - EUR | - | - | 53.026 | 954 | -8.667 | - | - | - | - | - |
| Net Profit/Loss - EUR | - | - | 52.082 | 398 | -8.701 | - | - | - | - | - |
| Employees | - | - | 1 | 1 | 0 | - | - | - | - | - |
Check the financial reports for the company - Doxalora Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 22.947 | 17.078 | 11.411 | - | - | - | - | - |
| Current Assets | - | - | 40.633 | 44.193 | 40.322 | - | - | - | - | - |
| Inventories | - | - | 1.117 | 1.035 | 1.698 | - | - | - | - | - |
| Receivables | - | - | 4.189 | 2.275 | 3.584 | - | - | - | - | - |
| Cash | - | - | 35.327 | 40.882 | 35.040 | - | - | - | - | - |
| Shareholders Funds | - | - | 52.126 | 51.567 | 41.867 | - | - | - | - | - |
| Social Capital | - | - | 44 | 43 | 42 | - | - | - | - | - |
| Debts | - | - | 11.454 | 9.703 | 9.866 | - | - | - | - | - |
| Income in Advance | - | - | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9329 - 9329" | |||||||||
| CAEN Financial Year |
9329
|
|||||||||
Comments - Doxalora Srl